Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Dengue Virus
80%
Dengue Serotypes
65%
Indonesia
61%
DNA Vaccine
48%
Mycobacterium Tuberculosis (M. tb)
46%
Vaccine Candidate
44%
Recombinant
44%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
42%
Non-structural Protein
41%
Jakarta
40%
Tuberculosis Vaccine
36%
COVID-19
36%
Dengue Infection
33%
Virus
32%
PcDNA3.1
31%
Humoral Immune Response
31%
Dengue
28%
Premembrane
28%
Immunogenicity
26%
Quantitative PCR
25%
Antibody Response
22%
Resuscitation-promoting Factor
21%
Peripheral Blood Mononuclear Cells
21%
QPCR Assay
19%
E Gene
19%
PE11
19%
Real-time RT-PCR
19%
Balb C Mice
16%
DENV-2
15%
DENV-3
14%
Recombinant Protein
14%
Mouse Serum
14%
Indonesian
13%
Clinical Manifestations
13%
Dengue Virus Type 3
13%
Nasopharyngeal Swab
13%
Immunization
13%
Cellular Immune Response
12%
3′-untranslated Region (3′-UTR)
12%
Glutathione S-transferase
11%
Interleukin-12 (IL-12)
11%
Recombinant DNA Vaccine
11%
Envelope Gene
11%
Beijing Strain
11%
Neutralizing Antibodies
11%
Dengue Fever
10%
Escherichia Coli
10%
SARS-CoV-2 Detection
10%
DENV Serotypes
9%
Corticosteroids
9%
Immunology and Microbiology
Dengue Virus
100%
Serotype
81%
Infection
76%
Infectious Disease
63%
Dengue Fever
59%
DNA Immunization
57%
Severe Acute Respiratory Syndrome Coronavirus 2
42%
BCG Vaccine
33%
Dengue Virus 1
32%
In Vitro
29%
Mycobacterium Tuberculosis
29%
Virus
29%
Humoral Immunity
28%
Immunogenicity
28%
COVID-19
25%
Dengue Virus 2
23%
Viral Disease
22%
Antibody Response
22%
Structural Protein
22%
Peripheral Blood Mononuclear Cell
22%
Quantitative Reverse Transcription Polymerase Chain Reaction
21%
Plasmid
21%
Cladistics
19%
Real Time Polymerase Chain Reaction
19%
Cell Line
15%
Bagg Albino Mouse
15%
Untranslated Region
13%
Neutralizing Antibody
13%
Dengue Virus 3
13%
Host Immune Response
12%
Env (Gene)
11%
Neutralization
10%
Reverse Transcription Polymerase Chain Reaction
10%
Cycle Threshold
9%
Tumor Necrosis Factor
9%
Pseudomonas
9%
Complement Factor B
9%
Real-Time Polymerase Chain Reaction
9%
Genetic Stability
9%
Escherichia coli
9%
Plasmid Vector
9%
Mediator
9%
Adoptive Immunity
9%
Interferon Gamma
9%
Growth Inhibition
9%
Human Bocavirus
9%
Virus-Like Particle
9%
Bombyx Mori
9%
Encephalitis Virus
9%
Viral Protein
9%
Pharmacology, Toxicology and Pharmaceutical Science
Dengue Virus
47%
SARS Coronavirus
28%
Infection
25%
Mycobacterium Tuberculosis
19%
Virus
18%
Dengue
14%
Escherichia coli
14%
Recombinant Protein
14%
Glutathione
14%
Diseases
13%
Virus Infection
10%
Tuberculosis
10%
Dengue Virus 2
10%
Nonstructural Protein 1
9%
Alternative Complement Pathway C3 C5 Convertase
9%
Bombyx Mori
9%
Medicinal Plant
9%
Adult Respiratory Distress Syndrome
9%
Dihydrofolate Reductase
9%
Cotrimoxazole
9%
Normal Human
9%
Glutathione Transferase
9%
Transferase
9%
Latent Tuberculosis
9%
Dihydropteroate Synthase
9%
Interferon
9%
Interleukin 12
9%
Antivirus Agent
9%
Plant Extract
9%
Virus Like Agent
9%
Cross-Sectional Study
9%
Corticosteroid
9%
Kaolinite
9%
Silicon Dioxide
9%
Viral Protein
9%
Synapsin I
9%
Clinical Trial
8%
Antigen
8%
Chimeric Protein
7%
Nucleic Acid
6%